These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 16306209

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Morphological and functional changes in p-glycoprotein during dexamethasone-induced hepatomegaly.
    Micuda S, Fuksa L, Mundlova L, Osterreicher J, Mokry J, Cermanova J, Brcakova E, Staud F, Pokorna P, Martinkova J.
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):296-303. PubMed ID: 17324141
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1.
    Takeuchi T, Yoshitomi S, Higuchi T, Ikemoto K, Niwa S, Ebihara T, Katoh M, Yokoi T, Asahi S.
    Pharm Res; 2006 Jul; 23(7):1460-72. PubMed ID: 16779700
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Insulin therapy restores impaired function and expression of P-glycoprotein in blood-brain barrier of experimental diabetes.
    Liu H, Liu X, Jia L, Liu Y, Yang H, Wang G, Xie L.
    Biochem Pharmacol; 2008 Apr 15; 75(8):1649-58. PubMed ID: 18299117
    [Abstract] [Full Text] [Related]

  • 9. Kinetic analyses for species differences in P-glycoprotein-mediated drug transport.
    Katoh M, Suzuyama N, Takeuchi T, Yoshitomi S, Asahi S, Yokoi T.
    J Pharm Sci; 2006 Dec 15; 95(12):2673-83. PubMed ID: 16892207
    [Abstract] [Full Text] [Related]

  • 10. 1Alpha,25-dihydroxyvitamin D3 up-regulates P-glycoprotein via the vitamin D receptor and not farnesoid X receptor in both fxr(-/-) and fxr(+/+) mice and increased renal and brain efflux of digoxin in mice in vivo.
    Chow EC, Durk MR, Cummins CL, Pang KS.
    J Pharmacol Exp Ther; 2011 Jun 15; 337(3):846-59. PubMed ID: 21421739
    [Abstract] [Full Text] [Related]

  • 11. Disposition of the cholesterol absorption inhibitor ezetimibe in mdr1a/b (-/-) mice.
    Oswald S, Koll C, Siegmund W.
    J Pharm Sci; 2007 Dec 15; 96(12):3478-84. PubMed ID: 17828742
    [Abstract] [Full Text] [Related]

  • 12. Estradiol regulation of P-glycoprotein expression in mouse kidney and human tubular epithelial cells, implication for renal clearance of drugs.
    Kanado Y, Tsurudome Y, Omata Y, Yasukochi S, Kusunose N, Akamine T, Matsunaga N, Koyanagi S, Ohdo S.
    Biochem Biophys Res Commun; 2019 Nov 12; 519(3):613-619. PubMed ID: 31540689
    [Abstract] [Full Text] [Related]

  • 13. Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism.
    Zhu HJ, Liu GQ.
    Life Sci; 2004 Jul 30; 75(11):1313-22. PubMed ID: 15234189
    [Abstract] [Full Text] [Related]

  • 14. Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the mdr1a and mdr1b Genes.
    Sukhai M, Yong A, Kalitsky J, Piquette-Miller M.
    Mol Cell Biol Res Commun; 2000 Oct 30; 4(4):248-56. PubMed ID: 11409920
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of organophosphate pesticide diazinon on expression and activity of intestinal P-glycoprotein.
    Lecoeur S, Videmann B, Mazallon M.
    Toxicol Lett; 2006 Mar 01; 161(3):200-9. PubMed ID: 16221533
    [Abstract] [Full Text] [Related]

  • 17. Selective and persistent upregulation of mdr1b mRNA and P-glycoprotein in the parahippocampal cortex of chronic epileptic rats.
    van Vliet E, Aronica E, Redeker S, Marchi N, Rizzi M, Vezzani A, Gorter J.
    Epilepsy Res; 2004 Mar 01; 60(2-3):203-13. PubMed ID: 15380564
    [Abstract] [Full Text] [Related]

  • 18. Delineating the Role of Various Factors in Renal Disposition of Digoxin through Application of Physiologically Based Kidney Model to Renal Impairment Populations.
    Scotcher D, Jones CR, Galetin A, Rostami-Hodjegan A.
    J Pharmacol Exp Ther; 2017 Mar 01; 360(3):484-495. PubMed ID: 28057840
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.